Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Antigliadin Antibodies in Predicting the Beneficial Effect of Gluten Free Diet in Unselected IBS Patients

NCT03492333 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT03492333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03492333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Antigliadin Antibodies in Predicting the Beneficial Effect of Gluten Free Diet in Unselected IBS Patients
Lead sponsor
McMaster University
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2012
Completion date
May 30, 2016
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ibs - irritable bowel syndrome